Bintrafusp Alfa and PDS01ADC Trial
Phase 1
100
about 7.4 years
18–120
1 site in MD
About this study
Researchers are testing a treatment with M7824, PDS01ADC, and SBRT to see if it can help fight cancer that has spread. Participants will receive these treatments through injections and infusions over several months while also providing samples for research purposes. The trial will last approximately 2 years.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Stereotactic body radiation therapy (SBRT)
- 2.Take M7824
- 3.Take PDS01ADC
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: safety and tolerability of PDS01ADC and M7824 alone or in combination with SBRT
Secondary: Objective response rate (ORR), Overall Survival (OS), Progression free survival (PFS)
Oncology